Use of Homeopathy in Patients Suffering from Long COVID-19 (LONGCOVIHOM): A Case Series

In some patients, coronavirus (COVID-19) can cause symptoms that last weeks or even months after the infection has gone. Long COVID-19 was defined as a confirmed initial COVID-19 infection, the presence of signs and symptoms more than four weeks after initial infection, and the persistence or appear...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:OBM Integrative and Complementary Medicine 2024-08, Vol.9 (3), p.1-21
Hauptverfasser: Takacs, Michael, Frass, Michael, Pohl-Schickinger, Anja, Fibert, Philippa, Lechleitner, Peter, Oberbaum, Menachem, Leisser, Ilse, Panhofer, Peter, Chandak, Kavita, Weiermayer, Petra
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In some patients, coronavirus (COVID-19) can cause symptoms that last weeks or even months after the infection has gone. Long COVID-19 was defined as a confirmed initial COVID-19 infection, the presence of signs and symptoms more than four weeks after initial infection, and the persistence or appearance of signs and symptoms that another condition cannot explain and did not exist before infection. This study aimed to describe the effect of adjunctive individualized homeopathic treatment delivered to Long COVID-19 patients with previously confirmed symptomatic SARS-CoV-2 infection. Fifteen female consecutive patients with Long COVID-19 were documented. The mean age was 48.5 ± 13.5 (SD) years. The symptoms of Long COVID-19 were diverse. None of the patients showed identical symptoms. All but one patient, hence 93.3%, experienced a timely improvement to complete healing after individualized homeopathic treatment, characterized by modified Naranjo criteria of at least 8 points. The average time until improvement/remission was 47.6 ± 34.6 days, and the median was 37 days. Our observations suggest that adjunctive individualized homeopathic treatment might be considered for patients suffering from Long COVID-19 even with severe long-term sequelae of COVID-19.
ISSN:2573-4393
2573-4393
DOI:10.21926/obm.icm.2403045